The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)

Singapore Health Services (SingHealth)

Status: Enrolling

Conditions: Valve Disease, Heart

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT07058935

2024-4264

Details and patient eligibility

About

A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.

Enrollment: 150 estimated patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≥ 21
2. Had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. (Prospective) OR Had at least one documented Tricuspid valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Tricuspid valve-in-valve/valve-in-ring procedure. (Prospective)

Exclusion criteria

1. Active endocarditis
2. Any other conditions which investigator deems unsuitable for participation.

Trial design

150 participants in 4 patient groups

Mitral Valve-in-Valve

Description:

Patients who have undergone or will undergo a transcatheter mitral valve-in-valve procedure.

Mitral Valve-in-Ring

Description:

Patients who have undergone or will undergo a transcatheter mitral valve-in-ring procedure.

Tricuspid Valve-in-Valve

Description:

Patients who have undergone or will undergo a transcatheter tricuspid valve-in-valve procedure.

Tricuspid Valve-in-Ring

Description:

Patients who have undergone or will undergo a transcatheter tricuspid valve-in-ring procedure.